Protego Bio Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Protego Biopharma is a San Diego-based biotechnology company focused on developing small-molecule therapeutics that target protein misfolding pathways. By reprogramming cellular processes to restore proper protein function, the company aims to address systemic amyloid diseases and other protein misfolding disorders with precision. Its work centers on pharmacological approaches that modulate protein folding to achieve therapeutic effects in affected patients. The organization operates in the biotechnology research sector, positioning itself around first-in-class small-molecule strategies for protein misfolding. It serves the broader biomedical community and patient populations impacted by rare and systemic diseases characterized by protein misfolding, aiming to advance candidates into clinical development. Recent leadership announcements and governance changes indicate ongoing efforts to strengthen its clinical and strategic capabilities from its San Diego base.